Ox-LDL inhibits the transcriptional activity of trans-activating pratein MHC II by NAD dependent of the deacetylase SIRT1
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the effects of oxidized low-density lipoprotein(ox-LDL) on the expression and activity of NAD-dependent deacetylase SIRT1 and its regulatory mechanisms on human adaptive immune function. Methods:Human primary peripheral blood monocytes were induced by human macrophage colony stimulating factor GM-CSF for 7 days in vitro. Well differentiated macrophages were treated with different concentrations(0~120 μg/ml) of ox-LDL for 48 h. The protein expression of SIRT1 was detected by Western blot. Real-time PCR was performed to examine the SIRT1 and HLA-DRα mRNA. Results:The protein expression of SIRT1 was decreased by ox-LDL in a concentration-dependent manner. The mRNA of SIRT1 treated by ox-LDL was significantly lower than that of the control group(P < 0.05).Resveratrol,which is the agonist of SIRT1,rescued the decreased expression of HLA-DRα induced by ox-LDL. Conclusion:The CIITA-dependent HLA-DRα promoter activity was decreased when treated with ox-LDL,which was induced by the change of mRNA and protein expression of SIRT1 in macrophage. Therefore,deacetylase SIRT1 may provide potential target for the treatment of atherosclerosis.

    Reference
    Related
    Cited by
Get Citation

方明明,宋鸣子,周红,吴晓燕. ox-LDL通过NAD依赖性脱乙酰酶SIRT1抑制MHC Ⅱ反式激活蛋白的转录活性[J].南京医科大学学报(自然科学版英文版),2014,(4):405-409.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 03,2013
  • Revised:
  • Adopted:
  • Online: April 18,2014
  • Published:
Article QR Code